Psoriasiform reactions to anti-tumor necrosis factor α therapy

Journal of Clinical Rheumatology

Volumn 19, Issue 7, 2013, Pages 377-381

  Nguyen, Khang ^a   Vleugels, Ruth Ann ^a   Velez, Nicole F ^a   Merola, Joseph F ^a,b   Qureshi, Abrar A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CHANNING LABORATORY   (United States)

Author keywords

biological therapy; drug eruptions; infliximab; psoriasis; rheumatoid arthritis; tumor necrosis factor

Indexed keywords

ADALIMUMAB; BETAMETHASONE; CALCIPOTRIOL; CLOBETASOL; ETANERCEPT; INFLIXIMAB; TRIAMCINOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ULOBETASOL PROPIONATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CROHN DISEASE; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PSORIASIS; PUSTULOSIS PALMOPLANTARIS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; ULTRAVIOLET B RADIATION;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ARTHRITIS, RHEUMATOID; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PREVALENCE; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; WITHHOLDING TREATMENT;

EID: 84885189916     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3182a702e8     Document Type: Article

References (15)

1. Chang J, Girgis L. Clinical use of antiYTNF-alpha biological agentsVa guide for GPs. Aust Fam Physician. 2007;36:1035-1038.
2. Moustou AE, Matekovits A, Dessinioti C, et al. Cutaneous side effects of antiYtumor necrosis factor biologic therapy\: A clinical review. J Am Acad Dermatol. 2009;61:486-504.
3. Ko JM, Gottlieb AB, Kerbleski JF. Induction and exacerbation of psoriasis with TNF-blockade therapy\: A review and analysis of 127 cases. J Dermatolog Treat. 2009;20:100-108.
4. Capkin E, Karkucak M, Yayli S, et al. Infliximab-induced palmoplantar psoriasis in a patient with ankylosing spondylitis. J Clin Rheumatol. 2011;17:293-294.
5. Bal A, Gurcay E, Aydog E, et al. Onset of psoriasis induced by infliximab. J Clin Rheumatol. 2008;14:128-129; author reply 130.
6. Wollina U, Hansel G, Koch A, et al. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol. 2008;9:1-14.
7. Bosch RI, Amo Ndel V, Manteca CF, et al. Psoriasis induced by anti-TNF probably not so uncommon. J Clin Rheumatol. 2008;14:128; author reply 130.
8. Shmidt E, Wetter DA, Ferguson SB, et al. Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-alpha inhibitors. The Mayo Clinic experience, 1998 to 2010. J Am Acad Dermatol. 2011.
9. Cuchacovich R, Espinoza CG, Virk Z, et al. Biologic therapy (TNF-alpha antagonists)Yinduced psoriasis\: A cytokine imbalance between TNF-alpha and IFN-alpha? J ClinRheumatol. 2008;14:353-356.
10. Cullen G, Kroshinsky D, Cheifetz AS, et al. Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease\: A new series and a review of 120 cases from the literature. Aliment Pharmacol Ther. 2011;34:1318-1327.
11. Pyrpasopoulou A, Chatzimichailidou S, Simoulidou E, et al. AntiYTNF-associated palmoplantar pustulosis. J Clin Rheumatol. 2010;16:138-139.
12. de Gannes GC, Ghoreishi M, Pope J, et al. Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol. 2007;143:223-231.
13. Scheinberg M, Goncalves DP, Laurindo IM. Anti-TNF agents inducing psoriasis\: A recognized adverse effect. J Clin Rheumatol. 2008;14:130.
14. Nestle FO, Conrad C, Tun-Kyi A, et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med. 2005;202:135-143.
15. Palucka AK, Blanck JP, Bennett L, et al. Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci U S A. 2005;102:3372-3377.